ImmuCell Corporation Stock Issued During Period, Shares, New Issues
ImmuCell Corporation (ICCC) reported Stock Issued During Period, Shares, New Issues of 1.08 million shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-03-30
- 2024-09-30: Stock Issued During Period, Shares, New Issues 9 month 1.08M shares.
- 2021-04-30: Stock Issued During Period, Shares, New Issues 63 month 4.55M shares.
| Period end | Stock Issued During Period, Shares, New Issues 9 month | Stock Issued During Period, Shares, New Issues 63 month |
|---|---|---|
| 2024-09-30 | 1.08M shares 10-Q · filed 2024-11-13 | |
| 2021-04-30 | 4.55M shares 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |